POINT: Routine Use of Autologous Stem Cell Transplantation in Multiple Myeloma – Cancer Network
|
POINT: Routine Use of Autologous Stem Cell Transplantation in Multiple Myeloma
Cancer Network [1] Nonetheless, autologous stem cell transplantation (ASCT) still is and will remain a mainstay of therapy, with 6,300 transplants done in the United States for myeloma in 2013.[2] Phase III trials continue to support the use of high-dose chemotherapy … |
